MTI Establishes a Medical Advisory Board for PolypDx™
We are very happy to announce a new Medical Advisory Board for PolypDx™. Members of this Advisory Board will help position PolypDx™ internationally, in their respective medical fields. We are excited to have such notable advisors, giving PolypDx™ the largest impact on the fight against colorectal cancer. PolypDx™ will give practitioners all around the world another option in the way we screen for colorectal cancer.
Read more about:
Dr. Richard Fedorak, MD, FRCPC, FRCP (London),
Dr. Franklin G. Berger, Director, Center for Colon Cancer Research, University of South Carolina,
Dr. Robert J. Bailey, MD & Clinical Professor of Medicine, and
Dr. Bo Jiang, MD & Professor, Tsinghua University Clinical Medical College here.